Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Fibroblast-activation protein: valuable marker of cutaneous epithelial malignancy.

El Khoury J, Kurban M, Kibbi AG, Abbas O.

Arch Dermatol Res. 2014 May;306(4):359-65. doi: 10.1007/s00403-014-1456-8. Epub 2014 Mar 5.

PMID:
24595644
2.

Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma.

Abbas O, Richards JE, Mahalingam M.

Mod Pathol. 2010 Nov;23(11):1535-43. doi: 10.1038/modpathol.2010.142. Epub 2010 Aug 13.

3.

Microcystic adnexal carcinoma: an immunohistochemical reappraisal.

Hoang MP, Dresser KA, Kapur P, High WA, Mahalingam M.

Mod Pathol. 2008 Feb;21(2):178-85. Epub 2007 Dec 7.

4.

Fibroblast activation protein regulates tumor-associated fibroblasts and epithelial ovarian cancer cells.

Lai D, Ma L, Wang F.

Int J Oncol. 2012 Aug;41(2):541-50. doi: 10.3892/ijo.2012.1475. Epub 2012 May 14.

PMID:
22614695
5.

The utility of ATF3 in distinguishing cutaneous squamous cell carcinoma among other cutaneous epithelial neoplasms.

Rose CL, Chakravarti N, Curry JL, Torres-Cabala CA, Bassett R, Prieto VG, Tetzlaff MT.

J Cutan Pathol. 2012 Aug;39(8):762-8. doi: 10.1111/j.1600-0560.2012.01938.x. Epub 2012 Jul 5.

PMID:
22764884
6.
7.

Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.

Dienus K, Bayat A, Gilmore BF, Seifert O.

Arch Dermatol Res. 2010 Dec;302(10):725-31. doi: 10.1007/s00403-010-1084-x. Epub 2010 Sep 26.

PMID:
20872224
8.

Malignant potential of keratoacanthoma.

Butcher RB 2nd.

Laryngoscope. 1979 Jul;89(7 Pt 1):1092-8.

PMID:
449552
9.

Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug.

Brennen WN, Rosen DM, Wang H, Isaacs JT, Denmeade SR.

J Natl Cancer Inst. 2012 Sep 5;104(17):1320-34. doi: 10.1093/jnci/djs336. Epub 2012 Aug 21.

10.

Cell proliferation and p53 protein expressions in cutaneous epithelial neoplasms.

Onodera H, Nakamura S, Sugai T.

Am J Dermatopathol. 1996 Dec;18(6):580-8.

PMID:
8989929
11.

PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma.

Sellheyer K, Krahl D.

Br J Dermatol. 2011 Jan;164(1):141-7. doi: 10.1111/j.1365-2133.2010.10045.x. Epub 2010 Dec 6.

PMID:
20846311
12.

Immunohistochemical expression of ezrin in cutaneous basal and squamous cell carcinomas.

Abdou AG, Maraee AH, El-Sayed EM, Elnaidany NF.

Ann Diagn Pathol. 2011 Dec;15(6):394-401. doi: 10.1016/j.anndiagpath.2011.05.005. Epub 2011 Aug 16.

PMID:
21849257
13.

Increased expression of CCN2, epithelial membrane antigen, and fibroblast activation protein in hepatocellular carcinoma with fibrous stroma showing aggressive behavior.

Kim GJ, Rhee H, Yoo JE, Ko JE, Lee JS, Kim H, Choi JS, Park YN.

PLoS One. 2014 Aug 15;9(8):e105094. doi: 10.1371/journal.pone.0105094. eCollection 2014.

14.
15.

Expression of CD10 in basal cell carcinoma.

Yada K, Kashima K, Daa T, Kitano S, Fujiwara S, Yokoyama S.

Am J Dermatopathol. 2004 Dec;26(6):463-71.

PMID:
15618927
16.

Immunohistochemical expression of MCM2 in nonmelanoma epithelial skin cancers.

Abdou AG, Elwahed MG, Serag El-Dien MM, Eldien DS.

Am J Dermatopathol. 2014 Dec;36(12):959-64. doi: 10.1097/DAD.0000000000000114.

PMID:
24936676
17.

Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.

Yang HM, Cabral E, Dadras SS, Cassarino DS.

Am J Dermatopathol. 2008 Dec;30(6):549-54. doi: 10.1097/DAD.0b013e31816d6513.

PMID:
19033927
18.

Perforating elastic fibers ('elastic fiber trapping') in the differentiation of keratoacanthoma, conventional squamous cell carcinoma and pseudocarcinomatous epithelial hyperplasia.

Shah K, Kazlouskaya V, Lal K, Molina D, Elston DM.

J Cutan Pathol. 2014 Feb;41(2):108-12. doi: 10.1111/cup.12247. Epub 2013 Nov 5.

PMID:
24138600
19.

Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.

Park HR, Min SK, Min K, Jun SY, Seo J, Kim KH, Choi J.

Int J Dermatol. 2010 Jan;49(1):48-52. doi: 10.1111/j.1365-4632.2009.04191.x.

PMID:
20465611
20.

Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer.

Tchou J, Zhang PJ, Bi Y, Satija C, Marjumdar R, Stephen TL, Lo A, Chen H, Mies C, June CH, Conejo-Garcia J, Puré E.

Hum Pathol. 2013 Nov;44(11):2549-57. doi: 10.1016/j.humpath.2013.06.016. Epub 2013 Sep 26.

Supplemental Content

Support Center